Neil Badiani
Institutional Account Manager at Paratek Pharmaceuticals- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Paratek Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
200 - 300 Employee
-
Institutional Account Manager
-
Feb 2021 - Present
IDN P&T, O.R, Hospitals - C-suite, Critical care Pulmonology, ED’s, Infectious DiseaseSell IV/Oral antibiotic to institutions including infusion centers that buy and bill IDN P&T, O.R, Hospitals - C-suite, Critical care Pulmonology, ED’s, Infectious DiseaseSell IV/Oral antibiotic to institutions including infusion centers that buy and bill
-
-
-
Antares Pharma Inc.
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Specialty Account Manager
-
Feb 2020 - Feb 2021
Sold injectable therapies to Urology, Endocrinology, and Rheumatology Specialists. Sold injectable therapies to Urology, Endocrinology, and Rheumatology Specialists.
-
-
-
Lupin Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Hospital Specialty Institution Representative
-
Jul 2017 - Jul 2019
July 2017 – March 2019 Hospital Institution Representative. Arizona/Nevada Lupin Pharmaceuticals➢ Multiple call points including accounts, Hospitals, Veteran’s Affairs, Defense, OBGYN Clinics, and Surgery Centers.➢ Promote rare disease hemorrhage therapies of IV/IM medication to PO, and anti-infective/antibiotics therapies.➢ 2018 73.7% retail increase, 26.3% Account increase, Top 20% launch of new antibiotic in Women’s Heath Care July 2017 – March 2019 Hospital Institution Representative. Arizona/Nevada Lupin Pharmaceuticals➢ Multiple call points including accounts, Hospitals, Veteran’s Affairs, Defense, OBGYN Clinics, and Surgery Centers.➢ Promote rare disease hemorrhage therapies of IV/IM medication to PO, and anti-infective/antibiotics therapies.➢ 2018 73.7% retail increase, 26.3% Account increase, Top 20% launch of new antibiotic in Women’s Heath Care
-
-
-
AcelRx Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Hospital Account Manager
-
2019 - 2019
March 2019- Present Hospital Account Manager. Arizona AcelRx Pharmaceuticals➢ Multiple call points: accounts, O.R, Hospitals - C-suite, DOP, DON, ED’s, PACU’s and Surgery Centers CFO’s.➢ 2019 Q1 rank #1/30 for Opioid Launch with REMS and a Buy and Bill, Market/Formulary Access March 2019- Present Hospital Account Manager. Arizona AcelRx Pharmaceuticals➢ Multiple call points: accounts, O.R, Hospitals - C-suite, DOP, DON, ED’s, PACU’s and Surgery Centers CFO’s.➢ 2019 Q1 rank #1/30 for Opioid Launch with REMS and a Buy and Bill, Market/Formulary Access
-
-
-
Eli Lilly and Company
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Injectable Biologic Sales Representative
-
Apr 2008 - Jun 2017
April 2008 - June 2017 Senior Representative. Eli Lilly & Company; 7 Performance Trip AwardsApril 2011 – June 2017 – Diabetes Sales Specialist , Eli Lilly & Company➢ Multiple call points including primary care, endocrinology specialists, and pharmacy. Sell diabetes portfolio including oral medications, injectable medications, and medical devices. ➢ 2017 Successful launch of “follow-on-biologic” product. Mentor to new sales representatives.. Advisory counsel.➢ 2016 Directors counsel and Advisory counsel. 117% to Plan➢ 2015 Capped biologic launch at 125%, 116% to plan. District Peer Award and MVP. Fifth to market GLP1 with REMS➢ 2014 107% to plan. Q4 capped at 125% with new product launch. **Rank D/C. Third to market SGLT2i➢ 2013 Achieved top 1% in Nation 113% to plan. Rank 15 of 714 reps➢ 2012 Achieved top 1% in Nation 119% to plan. Rank 3 of 714 Reps➢ 2011 Grew new territory to top 11%. Top 1% new product launch award. Third to market DPP4April 2008 - 2011 Hospital/Account Neuroscience Sales Representative, Eli Lilly & Company ➢ Multiple call points including accounts, Hospitals, Veteran’s Affairs, Defense, Mental Health and Community Health Centers. Sell neuroscience portfolio including oral, injectable, and “buy-and-bill” product with REMS protocol.➢ 2010 #1 in the state for new product launch of “buy-and-bill” injectable Long acting anti-psychotic with REMS➢ 2009 Ranking top 5% in Nation 107% to plan. Rank 7 of 120 reps➢ 2008 IDC Award for being in the top 1% of training class. Grew vacant territory to top 20%
-
-
-
Yellow Book USA,
-
United States
-
Retail
-
Media Sales Consultant – B2B Outside Sales
-
Jun 2007 - Apr 2008
Outstanding results with recruiting and establishing new accounts and growing existing accounts base➢ 2008 194.7% to Plan➢ 2008 Top 1% Sales Performance➢ 2007 100% to plan at 50% benchmark Outstanding results with recruiting and establishing new accounts and growing existing accounts base➢ 2008 194.7% to Plan➢ 2008 Top 1% Sales Performance➢ 2007 100% to plan at 50% benchmark
-
-
-
Topgun Academy Inc.
-
United States
-
Civic and Social Organizations
-
B2B Outside Sales, Territory Manager
-
Jun 2002 - Jun 2007
B2B telecommunications sales, residential and commercial. 2006 Award for fastest growing team in the region. Top 5% Performance 2005 Promoted to Executive Representative. Top 5% Performance 2004 Promoted to Regional Representative. Top 10% performance 2003 Promoted to Senior Representative. Top 10% performance 2002 Award and Trip for new business growth B2B telecommunications sales, residential and commercial. 2006 Award for fastest growing team in the region. Top 5% Performance 2005 Promoted to Executive Representative. Top 5% Performance 2004 Promoted to Regional Representative. Top 10% performance 2003 Promoted to Senior Representative. Top 10% performance 2002 Award and Trip for new business growth
-
-
Education
-
Northern Arizona University
Bachelor's degree, Psychology -
University of Phoenix
Master's degree, Psychology -
University of Phoenix
Master of Business Administration - MBA, Business